> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Extended on Combo Product Bridging Guide
- URL: https://www.fdaweb.com/comments-extended-on-combo-product-bridging-guide/
- Published: 2020-02-14T12:00:00.000Z
- Updated: 2026-09-14T16:03:16.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5146094

*Federal Register* notice: FDA has extended until 4/20 the comment period for a 12/2019 draft guidance on *Bridging for Drug-Device and Biologic-Device Combination Products*. The [guidance](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/bridging-drug-device-and-biologic-device-combination-products?ref=fdaweb.com) seeks to clarify how to bridge the information gathered from another development program to leverage that information in support of an application. It also describes an approach for an applicant to identify and address informational gaps for an application. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-02-14/pdf/2020-03023.pdf?ref=fdaweb.com).